ADAR1 Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

ADAR1 Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17,500	Closed	-$1.06M	–	290
2026 Q1	$1.06M	Sell	17,500 -2,500	-13%	-$146K	0.06%	153
2025 Q4	$1.08M	Buy	+20,000	New	+$962K	0.08%	127

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ADAR1 Capital Management's BMY Position: Q2 2026 in Review

ADAR1 Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 17,500 shares — an estimated $1.06M sold.

ADAR1 Capital Management first reported a position in BMY in Q4 2025 and held it in 2 quarters. The position peaked at $1.08M in Q4 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

ADAR1 Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
ADAR1 Capital Management sold 17,500 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.06M.
ADAR1 Capital Management first reported a position in Bristol-Myers Squibb in Q4 2025 and held it in 2 quarters.
ADAR1 Capital Management's Bristol-Myers Squibb position peaked at $1.08M in Q4 2025.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.